Cancers, Vol. 16, Pages 1571: Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance

Cancers, Vol. 16, Pages 1571: Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance Cancers doi: 10.3390/cancers16081571 Authors: Fateeva Eddy Chen Melanoma is the most aggressive and deadly form of skin cancer due to its high propensity to metastasize to distant organs. Significant progress has been made in the last few decades in melanoma therapeutics, most notably in targeted therapy and immunotherapy. These approaches have greatly improved treatment response outcomes; however, they remain limited in their abilities to hinder disease progression due, in part, to the onset of acquired resistance. In parallel, intrinsic resistance to therapy remains an issue to be resolved. In this review, we summarize currently available therapeutic options for melanoma treatment and focus on possible mechanisms that drive therapeutic resistance. A better understanding of therapy resistance will provide improved rational strategies to overcome these obstacles.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research